<<
>>

REFERENCES

The complete list of references can be found at www.expertconsult.com.

REFERENCES:

1. Stockham SL, Scott MA: Hemostasis. In Stockham SL, Scott MA, editors: Fundamentals of veterinary clinical pathology, ed 2, Ames, IA, 2008, Blackwell, p 259.

2. Stockham SL, Scott MA: Platelets. In Stockham SL, Scott MA, editors: Fundamentals of veterinary clinical pathology, ed 2, Ames, IA, 2008, Blackwell, p 223.

3. Kuter DJ: The physiology of platelet production, Stem Cells 14(Suppl 1):88-101, 1996.

4. Hinchcliff KW Kociba GJ, Mitten LA: Diagnosis of EDTA-dependent pseudothrombocytopenia in a horse, JAm Vet Med Assoc 203:1715-1716, 1993.

5. Cain GR, East N, Moore PF: Myelofibrosis in young pygmy goats, Comp Haematol Int 4:167-172, 1994.

6. Crawford TB, Wardrop KJ, Tornquist SJ, et al: A primary production deficit in the thrombocytopenia of equine infectious anemia, J Virol 70:7842-7850, 1996.

7. Russell KE, Perkins PC, Hoffman MR, et al: Platelets from thrombocy­topenic ponies acutely infected with equine infectious anemia virus are activated in vivo and hypofunctional, Virology 259:7-19, 1999.

8. McGovern KF, Lascola KM, Davis E, et al: T-cell lymphoma with immune- mediated anemia and thrombocytopenia in a horse, J Vet Intern Med 25:1181-1185, 2011.

9. McGurrin MK, Arroyo LG, Bienzle D: Flow cytometric detection of platelet-bound antibody in three horses with immune-mediated throm­bocytopenia, J Am Vet Med Assoc 224:83-87, 53, 2004.

10. Sellon DC, Spaulding K, Breuhaus BA, et al: Hepatic abscesses in three horses, J Am Vet Med Assoc 216:864-865, 882-887, 2000.

11. Borjesson DL, Simon SI, Tablin F, et al: Thrombocytopenia in a mouse model of human granulocytic ehrlichiosis, J Infect Dis 184:1475-1479, 2001.

12. Granick JL, Reneer DV, Carlyon JA, et al: Anaplasma phagocytophilum infects cells of the megakaryocytic lineage through sialylated ligands but fails to alter platelet production, J Med Microbiol 57:416-423, 2008.

13. Morris DD, Beech J: Disseminated intravascular coagulation in six horses, J Am Vet Med Assoc 183:1067-1072, 1983.

14. Dodds WJ: Hemostasis. In Kaneko JJ, Harvey JW, Bruss ML, editors: Clinical biochemistry of domestic animals, San Diego, CA, 1997, Academic Press, p 241.

15. Gerhards H: [Consumption coagulopathy and hyperfibrinolysis in horses with colic], Zentralbl Veterinarmed A 30:373-386, 1983.

16. Irmak K, Sen I, Col R, et al: The evaluation of coagulation profiles in calves with suspected septic shock, Vet Res Commun 30:497-503, 2006.

17. Monreal L, Angles A, Espada Y, et al: Hypercoagulation and hypofibrinolysis in horses with colic and DIC, Equine Vet J Suppl 19-25, 2000.

18. Del Piero F, Wilkins PA, Lopez JW, et al: Equine viral arteritis in newborn foals: clinical, pathological, serological, microbiological and immunohis­tochemical observations, Equine Vet J 29:178-185, 1997.

19. Goerge T, Ho-Tin-Noe B, Carbo C, et al: Inflammation induces hemorrhage in thrombocytopenia, Blood 111:4958-4964, 2008.

20. Segura D, Monreal L: Poor reproducibility of template bleeding time in horses, J Vet Intern Med 22:238-241, 2008.

21. Sanz MG, Wills TB, Christopherson P, et al: Glanzmann thrombasthenia in a 17-year-old peruvian paso mare, Vet Clin Pathol 40:48-51, 2011.

22. Livesey L, Christopherson P, Hammond A, et al: Platelet dysfunction (Glanzmann’s thrombasthenia) in horses, J Vet Intern Med 19:917-919, 2005.

23. Macieira S, Rivard GE, Champagne J, et al: Glanzmann thrombasthenia in an Oldenbourg filly, Vet Clin Pathol 36:204-208, 2007.

24. Macieira S, Lussier J, Bedard C: Characterization of the CDNA and genomic DNA sequence encoding for the platelet integrin alpha IIB and beta III in a horse with Glanzmann thrombasthenia, Can J Vet Res 75:222-227, 2011.

25. Norris JW, Pombo M, Shirley E, et al: Association of factor V secretion with protein kinase B signaling in platelets from horses with atypical equine thrombasthenia, J Vet Intern Med 29:1387-1394, 2015.

26. Shiraishi M, Ogawa H, Ikeda M, et al: Platelet dysfunction in Chediak- Higashi syndrome-affected cattle, J Vet Med Sci 64:751-760, 2002.

27. Mapletoft RJ, Schmutz SM, Searcy GP: A study of the inheritance of a bleeding disorder in Simmental cattle, Can Vet J 41:791-793, 2000.

28. Sullivan PS, Grubbs ST, Olchowy TW, et al: Bleeding diathesis associated with variant von Willebrand factor in a Simmental calf, J Am Vet Med Assoc 205:1763-1766, 1994.

29. Brooks M, Leith GS, Allen AK, et al: Bleeding disorder (von Willebrand disease) in a quarter horse, J Am Vet Med Assoc 198:114-116, 1991.

30. Mischke R, Junker J, Deegen E: Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma, Vet J 171:114-119, 2006.

31. House AM, Barton MH, Williamson LH: One-stage prothrombin time, activated partial thromboplastin time, thrombin time, fibrin degradation product concentration, and antithrombin activity in healthy adult alpacas, Vet Clin Pathol 40:195-197, 2011.

32. Archer RK, Allen BG: True hemophilia in horses, Vet Rec 91:655, 1972.

33. Feldman BF, Giacopuzzi RL: Hemophilia A (Factor VIII deficiency) in a colt, Equine Pract 4:24, 1982.

34. Geor RJ, Jackson ML, Lewis KD, et al: Prekallikrein deficiency in a family of Belgian horses, J Am Vet Med Assoc 197:741-745, 1990.

35. Hinton M, Jones DR, Lewis IM, et al: A clotting defect in an Arab colt foal, Equine Vet J 9:1-3, 1977.

36. Turrentine MA, Sculley PW, Green EM, et al: Prekallikrein deficiency in a family of miniature horses, Am J Vet Res 47:2464-2467, 1986.

37. Gentry PA, Ross ML: Failure of routine coagulation screening tests to detect heterozygous state of bovine factor XI deficiency, Vet Clin Pathol 15:12-16, 1986.

38. Senthil M, Chaudhary P, Smith DD, et al: A shortened activated partial thromboplastin time predicts the risk of catheter-associated venous thrombosis in cancer patients, Thromb Res 134:165-168, 2014.

39.

Song J, Drobatz KJ, Silverstein DC: Retrospective evaluation of shortened prothrombin time or activated partial thromboplastin time for the diagnosis of hypercoagulability in dogs: 25 cases (2006-2011), J Vet Emerg Crit Care (San Antonio) 26:398-405, 2016.

40. Tripodi A, Chantarangkul V, Martinelli I, et al: A shortened activated partial thromboplastin time is associated with the risk of venous throm­boembolism, Blood 104:3631-3634, 2004.

41. Stokol T, Erb HN, De Wilde L, et al: Evaluation of latex agglutination kits for detection of fibrin(ogen) degradation products and D-dimer in healthy horses and horses with severe colic, Vet Clin Pathol 34:375-382, 2005.

42. Wittek T, Grosche A, Locher LF, et al: Diagnostic accuracy of D-dimer and other peritoneal fluid analysis measurements in dairy cows with peritonitis, J Vet Intern Med 24:1211-1217, 2010.

43. Barton MH, Morris DD, Crowe N, et al: Hemostatic indices in healthy foals from birth to one month of age, J Vet Diagn Invest 7:380-385, 1995.

44. Johnstone IB, Petersen D, Crane S: Antithrombin III (ATIII) activity in plasmas from normal and diseased horses, and in normal canine, bovine and human plasmas, Vet Clin Pathol 16:14-18, 1987.

45. Barton MH, Morris DD, Norton N, et al: Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia, J Vet Intern Med 12:26-35, 1998.

46. Hellebrekers LJ, Slappendel RJ, van den Brom WE: Effect of sodium heparin and antithrombin III concentration on activated partial thrombo­plastin time in the dog, Am J Vet Res 46:1460-1462, 1985.

47. Gigante A, Barbano B, Sardo L, et al: Hypercoagulability and nephrotic syndrome, Curr Vasc Pharmacol 2012.

48. LaRue MJ, Murtaugh RJ: Pulmonary thromboembolism in dogs: 47 cases (1986-1987), J Am Vet Med Assoc 197:1368-1372, 1990.

49. Prasse KW, Topper MJ, Moore JN, et al: Analysis of hemostasis in horses with colic, J Am Vet Med Assoc 203:685-693, 1993.

50. Concannon PW, Gimpel T, Newton L, et al: Postimplantation increase in plasma fibrinogen concentration with increase in relaxin concentration in pregnant dogs, Am J Vet Res 57:1382-1385, 1996.

51. Feige K, Kastner SB, Dempfle CE, et al: Changes in coagulation and markers of fibrinolysis in horses undergoing colic surgery, J Vet Med A Physiol Pathol Clin Med 50:30-36, 2003.

52. Iselin BM, Willimann PF, Seifert B, et al: Isolated reduction of haematocrit does not compromise in vitro blood coagulation, Br J Anaesth 87:246-249, 2001.

53. Spiezia L, Radu C, Marchioro P, et al: Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients, Thromb Haemost 100:1106-1110, 2008.

54. Greene LA, Chen S, Seery C, et al: Beyond the platelet count: immature platelet fraction and thromboelastometry correlate with bleeding in patients with immune thrombocytopenia, Br J Haematol 166:592-600, 2014.

55. Bucknoff MC, Hanel RM, Marks SL, et al: Evaluation of thromboelas­tography for prediction of clinical bleeding in thrombocytopenic dogs after total body irradiation and hematopoietic cell transplantation, Am J Vet Res 75:425-432, 2014.

56. Dunkel B, Chan DL, Boston R, et al: Association between hypercoagulability and decreased survival in horses with ischemic or inflammatory gastro­intestinal disease, J Vet Intern Med 24:1467-1474, 2010.

57. Epstein KL, Brainard BM, Gomez-Ibanez SE, et al: Thrombelastography in horses with acute gastrointestinal disease, J Vet Intern Med 25:307-314, 2011.

58. Mendez-Angulo JL, Mudge MC, Vilar-Saavedra P, et al: Thromboelas­tography in healthy horses and horses with inflammatory gastrointestinal disorders and suspected coagulopathies, J Vet Emerg Crit Care (San Antonio) 20:488-493, 2010.

59. Dallap Schaer BL, Wilkins PA, Boston R, et al: Preliminary evaluation of hemostasis in neonatal foals using a viscoelastic coagulation and platelet function analyzer, J Vet Emerg Crit Care (San Antonio) 19:81-87, 2009.

60. Mendez-Angulo JL, Mudge M, Zaldivar-Lopez S, et al: Thromboelastog­raphy in healthy, sick non-septic and septic neonatal foals, Aust Vet J 89:500-505, 2011.

61. McKenzie EC, Esser MM, McNitt SE, et al: Effect of infusion of equine plasma or 6% hydroxyethyl starch (600/0.75) solution on plasma colloid osmotic pressure in healthy horses, Am J Vet Res 77:708-714, 2016.

62. Viljoen A, Page PC, Fosgate GT, et al: Coagulation, oncotic and haemo- dilutional effects of a third-generation hydroxyethyl starch (130/0.4) solution in horses, Equine Vet J 46:739-744, 2014.

63. Hepworth-Warren KL, Wong DM, Hay-Kraus BL, et al: Effects of administration of a synthetic low molecular weight/low molar substitu­tion hydroxyethyl starch solution in healthy neonatal foals, Can Vet J 56:1069-1074, 2015.

64. Woodman J, Wagg CR, Boysen SR, et al: Evaluation of coagulation via thromboelastography in healthy horses administered dexamethasone, Can Vet J 56:1271-1274, 2015.

65. Borrelli A, Bellino C, Bozzetta E, et al: Thromboelastometry in veal calves to detect hemostatic variations caused by low doses of dexamethasone treatment, BMC Vet Res 9:55, 2013.

66. Morris DD, Messick J, Whitlock RH, et al: Effect of equine ehrlichial colitis on the hemostatic system in ponies, Am J Vet Res 49:1030-1036, 1988.

<< | >>
Source: Smith Bradford P., Van Metre David C., Pusterla Nicola (eds.). Large Animal Internal Medicine. Part 1. 6th edition. — Elsevier,2020. — 2279 p.. 2020

More on the topic REFERENCES: